NeuroLINCS, the Neurological Library of Integrated Network- Based Cellular Signatures, is an NIH-funded collaborative consortium between research groups with expertise in iPSC technology, disease modeling, OMICS methods, and computational biology. The overall goal is to understand the causes of neurological disorders and to develop novel therapies. The NeuroLINCS study has generated iPSCs derived from participants at risk for or affected by amyotrophic lateral sclerosis (ALS), Huntington’s disease, and spinal muscular atrophy.